Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Impaired Remyelination in a Mouse Model of Huntington Disease.

Teo RTY, Ferrari Bardile C, Tay YL, Yusof NABM, Kreidy CA, Tan LJ, Pouladi MA.

Mol Neurobiol. 2019 Apr 2. doi: 10.1007/s12035-019-1579-1. [Epub ahead of print]

PMID:
30937636
2.

Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.

Santiago González DA, Cheli VT, Zamora NN, Lama TN, Spreuer V, Murphy GG, Paez PM.

J Neurosci. 2017 Oct 18;37(42):10038-10051. doi: 10.1523/JNEUROSCI.1787-17.2017. Epub 2017 Sep 12.

3.

Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.

Teo RT, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, To XV, Guo L, Rajendran R, Novati A, Calaminus C, Riess O, Hayden MR, Nguyen HP, Chuang KH, Pouladi MA.

Hum Mol Genet. 2016 Jul 1;25(13):2621-2632. Epub 2016 Apr 28.

4.

Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.

Zhang M, Zhan XL, Ma ZY, Chen XS, Cai QY, Yao ZX.

Exp Biol Med (Maywood). 2015 Sep;240(9):1183-96. doi: 10.1177/1535370214565975. Epub 2015 Jan 10.

5.

Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.

Martin NA, Molnar V, Szilagyi GT, Elkjaer ML, Nawrocki A, Okarmus J, Wlodarczyk A, Thygesen EK, Palkovits M, Gallyas F Jr, Larsen MR, Lassmann H, Benedikz E, Owens T, Svenningsen AF, Illes Z.

Front Immunol. 2018 Mar 12;9:490. doi: 10.3389/fimmu.2018.00490. eCollection 2018.

6.

Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.

Llufriu-Dabén G, Carrete A, Chierto E, Mailleux J, Camand E, Simon A, Vanmierlo T, Rose C, Allinquant B, Hendriks JJA, Massaad C, Meffre D, Jafarian-Tehrani M.

Neurobiol Dis. 2018 Jan;109(Pt A):11-24. doi: 10.1016/j.nbd.2017.09.008. Epub 2017 Sep 18.

PMID:
28923597
7.

Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease.

Garcia-Miralles M, Yusof NABM, Tan JY, Radulescu CI, Sidik H, Tan LJ, Belinson H, Zach N, Hayden MR, Pouladi MA.

Mol Neurobiol. 2018 Oct 17. doi: 10.1007/s12035-018-1393-1. [Epub ahead of print]

PMID:
30334188
8.

rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.

Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.

Neurobiol Dis. 2017 Sep;105:142-155. doi: 10.1016/j.nbd.2017.05.015. Epub 2017 May 30.

9.

Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.

Silvestroff L, Bartucci S, Pasquini J, Franco P.

Exp Neurol. 2012 May;235(1):357-67. doi: 10.1016/j.expneurol.2012.02.018. Epub 2012 Mar 7.

PMID:
22421533
10.

Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.

Paez PM, Cheli VT, Ghiani CA, Spreuer V, Handley VW, Campagnoni AT.

Glia. 2012 Jul;60(7):1078-93. doi: 10.1002/glia.22336. Epub 2012 Mar 23.

PMID:
22447683
11.

The Role of Galectin-3: From Oligodendroglial Differentiation and Myelination to Demyelination and Remyelination Processes in a Cuprizone-Induced Demyelination Model.

Hoyos HC, Marder M, Ulrich R, Gudi V, Stangel M, Rabinovich GA, Pasquini LA, Pasquini JM.

Adv Exp Med Biol. 2016;949:311-332.

PMID:
27714696
12.
13.

Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.

Hoyos HC, Rinaldi M, Mendez-Huergo SP, Marder M, Rabinovich GA, Pasquini JM, Pasquini LA.

Neurobiol Dis. 2014 Feb;62:441-55. doi: 10.1016/j.nbd.2013.10.023. Epub 2013 Oct 31.

PMID:
24184798
14.

Effect of Notch1 gene on remyelination in multiple sclerosis in mouse models of acute demyelination.

Fan H, Zhao JG, Yan JQ, Du GQ, Fu QZ, Shi J, Yang YH, Du XW, Bai XL.

J Cell Biochem. 2018 Nov;119(11):9284-9294. doi: 10.1002/jcb.27197. Epub 2018 Jul 16.

PMID:
30010211
15.

Geissoschizine methyl ether, an alkaloid from the Uncaria hook, improves remyelination after cuprizone-induced demyelination in medial prefrontal cortex of adult mice.

Morita S, Tatsumi K, Makinodan M, Okuda H, Kishimoto T, Wanaka A.

Neurochem Res. 2014 Jan;39(1):59-67. doi: 10.1007/s11064-013-1190-1. Epub 2013 Nov 6.

PMID:
24190599
16.

MiR-146a promotes remyelination in a cuprizone model of demyelinating injury.

Zhang J, Zhang ZG, Lu M, Wang X, Shang X, Elias SB, Chopp M.

Neuroscience. 2017 Apr 21;348:252-263. doi: 10.1016/j.neuroscience.2017.02.029. Epub 2017 Feb 23.

PMID:
28237816
17.
18.

Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Steelman AJ, Thompson JP, Li J.

Neurosci Res. 2012 Jan;72(1):32-42. doi: 10.1016/j.neures.2011.10.002. Epub 2011 Oct 12.

19.

The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.

Zeldich E, Chen CD, Avila R, Medicetty S, Abraham CR.

J Mol Neurosci. 2015 Oct;57(2):185-96. doi: 10.1007/s12031-015-0598-2. Epub 2015 Jun 12.

PMID:
26067431
20.

Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.

Baxi EG, DeBruin J, Jin J, Strasburger HJ, Smith MD, Orthmann-Murphy JL, Schott JT, Fairchild AN, Bergles DE, Calabresi PA.

Glia. 2017 Dec;65(12):2087-2098. doi: 10.1002/glia.23229. Epub 2017 Sep 22.

Supplemental Content

Support Center